Children with a rare form of cancer called neuroblastoma which hasn't responded to initial treatment or that has relapsed may ...

Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA / ACCESS Newswire / ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

Only 6% of trials for FDA-approved drugs match America's diversity. Analysis reveals how trial location and design choices ...

Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple ...

Newly published research in the Journal of Clinical Oncology reports on a phase 2 clinical trial that finds that children with a rare form of cancer called neuroblastoma which hasn’t responded to ...

Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple ...

After decades of research, Phase 1 of a Cleveland Clinic study shows a breast cancer vaccine is safe and triggers an immune ...

The combination of talquetamab-tgvs and pomalidomide achieved an 85.7% objective response rate in relapsed/refractory multiple myeloma patients. Median progression-free survival was 25.8 months, with ...

Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed ...

An experimental oral drug claims to do the work of medications like GLP-1s without losing muscle mass.

Inflammation plays a critical role in the development and progression of neurovascular disorders and stroke, impacting both acute and chronic phases of ...